Microsoft 's (NASDAQ: MSFT) blowout quarter briefly propelled the stock across the $4 trillion threshold, allowing the tech ...

A compound growth rate of 19% from 2027 to 2035 gets you to $1 trillion in revenue. At 45% net margin and an earnings ...

aTyr's lead drug, efzofitimod, just completed enrollment in its phase 3 EFZO-FIT trial for pulmonary sarcoidosis, with ...

OpenAI today launched GPT-5, its most sophisticated artificial intelligence model yet, delivering what chief executive Sam ...